Vasopressin and disorders of water balance: The physiology and pathophysiology of vasopressin

Annals of Clinical Biochemistry

Volumn 44, Issue 5, 2007, Pages 417-431

  Ball, S G ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALKYLATING AGENT; ANTICONVULSIVE AGENT; AQUAPORIN; DOPAMINE RECEPTOR BLOCKING AGENT; LOOP DIURETIC AGENT; OPIATE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; SULFONYLUREA; THIAZIDE DIURETIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMETAPHAN; VASOPRESSIN; VASOPRESSIN RECEPTOR; VINCA ALKALOID; SODIUM; VASOPRESSIN DERIVATIVE;

ADIPSIA; DIABETES INSIPIDUS; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; ELECTROLYTE DISTURBANCE; HORMONE ACTION; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HYPONATREMIA; HYPOTENSION; HYPOTHALAMUS; INAPPROPRIATE VASOPRESSIN SECRETION; NEPHROGENIC DIABETES INSIPIDUS; NEUROPHYSIOLOGY; OSMOREGULATION; PATHOPHYSIOLOGY; PLASMA OSMOLALITY; PRIORITY JOURNAL; REVIEW; THIRST; WATER DEPRIVATION; WATER LOADING; BODY WATER; CHEMICAL STRUCTURE; DIURESIS; ELECTROLYTE BALANCE; HYPERNATREMIA; KIDNEY; METABOLIC DISORDER; METABOLISM; PHYSIOLOGY; POLYURIA;

AQUAPORINS; BODY WATER; DIABETES INSIPIDUS; DIURESIS; HUMANS; HYPERNATREMIA; HYPONATREMIA; KIDNEY; MOLECULAR STRUCTURE; POLYURIA; RECEPTORS, VASOPRESSIN; SODIUM; THIRST; VASOPRESSINS; WATER-ELECTROLYTE BALANCE; WATER-ELECTROLYTE IMBALANCE;

EID: 38449118263     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/000456307781646030     Document Type: Review

References (102)

1. Schally AV. Hormones of the neurohypophysis. In: Lock W, Schally AV, eds. The Hypothalamus and Pituitary in Health and Disease. Springfield, IL: Charles C Thomas, 1972: 154-71
2. Mohr E, Schmitz E, Richter D. A single rat genomic cDNA fragment encodes both the oxytocin and vasopressin genes separated by 11 kilobases and orientated in opposite transcriptional directions. Biochemie 1988; 70: 649-54
3. Carter DA, Murphy D. Rapid changes in poly(A) tail length of vasopressin and oxytocin mRNAs from common early components of neurohypophyseal peptide gene activation following physiological stimulation. Neuroendocrinology 1991; 5: 1-6
4. Mohr E, Kachele I, Mullin C, et al. Rat vasopressin mRNA: a model system to characterize cis-acting elements and transacting factors in dendritic mRNA sorting. Prog Brain Res 2002; 139: 211-24
5. Russell JT, Brownstein MJ, Gainer H. Biosynthesis of vasopressin, oxytocin and neurophysins: isolation and characterization of two common precursors (propressophysin and prooxyphysin). Endocrinology 1980; 107: 1880-91
6. Dutton A, Dyball REJ. Phasic firing enhances vasopressin release from the rat neurohypophysis. J Physiol 1979; 290: 433-40
7. Lauson HD. Metabolism of neurohypophysial hormones. In: Knobil E, Sawyer WH, eds. Handbook of Physiology, section 7: Endocrinology. Vol 4, part 1. Washington, DC: American Physiological Society, 1974: 287-393
8. Bichet DG, Arthus M-F, Barjon JN, et al. Human platelet fraction arginine-vasopressin: potential physiological role. J Clin Invest 1987; 79: 881-7
9. Zingg HH. Vasopressin and oxytocin receptors. Baillieres Clin Endocrinol Metab 1996; 10: 75-96
10. King LS, Yasui M. Aquaporins and disease: lessons from mice to humans. Trends Endocrinol Metab 2002; 13: 355-60
11. Verkman AS. Physiological importance of aquaporin water channels. Ann Med 2002; 34: 192-200
12. Marples D. Water channels: who needs them anyway? Lancet 2000; 355: 1571-2
13. King LS, Choi M, Fernandez PC, Cartron JP, Agre P. Defective urinary concentrating ability due to a complete deficiency of aquaporin-1. N Engl J Med 2001; 345: 175-9
14. Ishikawa S, Saito K, Kasono K. Pathological role of aquaporin-2 in impaired water excretion and hyponatraemia. J Neuroendocrinol 2004; 16: 293-6
15. Nielson S, Knepper MA. Vasopressin activates collecting duct urea transporters and water channels by distinct physical processes. Am J Physiol 1993; 265: F204-13
16. Knepper MA, Sands JM, Chou CL. Independence of water and urea transport in the rat inner medullary collecting duct. Am J Physiol 1989; 256: F610-21
17. Imbert-Teboul M, Chabardes D, Montegut M, et al. Vasopressin-dependent adenylate cyclase activities in the rat kidney medulla: evidence for two separate sites of action. Endocrinology 1978; 102: 1254-61
18. Wittner M, Di Stefano A, Wangemann P, et al. Differential effects of ADH on sodium, chloride, potassium, calcium and magnesium transport in cortical and medullary thick ascending limbs of mouse nephron. Pflugers Arch 1988; 412: 516-23
19. Hebert SC, Culpepper RM, Andreoli TE. NaCl transport in mouse medullary thick ascending limbs: I. Functional nephron heterogeneity and ADH-stimulated NaCl cotransport. Am J Physiol 1981; 241: 412-31
20. Montani JP, Liard JF, Schoun J, Mohring J. Hemodynamic effects of exogenous and endogenous vasopressin at low plasma concentrations in conscious dogs. Circ Res 1980; 47: 346-55
21. Altura BM, Altura BT. Actions of vasopressin, oxytocin, and synthetic analogs on vascular smooth muscle. Fed Proc 1984; 43: 80-6
22. Aisenbrey GA, Handelman WA, Arnold P, et al. Vascular effects of arginine vasopressin during fluid deprivation. J Clin Invest 1981; 67: 961-8
23. Liard J-F. Acute hemodynamic effects of antidiuretic agents. In: Cowley AW, Liard J-F, Ausiello DA, eds. Vasopressin: Cellular and Integrative Functions. New York: Raven Press, 1988: 461-6
24. Du Pasquier D, Loup F, Dubois-Dauphin M, et al. Binding sites for vasopressin in the human pituitary are associated with corticotrophs and may differ from other known vasopressin receptors. J Neuroendocrinol 1991; 3: 237-47
25. Sawchenko PE, Swanson LW, Vale WW. Co-expression of corticotrophin- releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat. Proc Natl Acad Sci USA 1984; 81: 1877-83
26. Baldino F, Davis LG. Glucocorticoid regulation of vasopressin messenger RNA In: Uhl GR, ed. In Situ Hybridization in the Brain. New York: Plenum Press, 1986: 97
27. Young LJ, Nilsen R, Waymire KG, et al. Increased affiliative response to vasopressin in mice expressing the V1a receptor from a monogamous vole. Nature 1999; 400: 766-8
28. Bielsky IF, Hu S-B, Szegda KL, et al. Profound impairment in social recognition and reduction in anxiety-like behaviour in vasopressin V1a receptor knockout mice. Neuropsychopharmacology 2004; 29: 483-93
29. Robertson GL, Shelton RL, Athar S. The osmoregulation of vasopressin. Kidney Int 1976; 10: 25-37
30. Hammer M, Ladefoged J, Olgaard K. Relationship between plasma osmolality and plasma vasopressin in human subjects. Am J Physiol 1980; 238: E313-17
31. Baylis PH, Thompson CJ. Osmoregulation of vasopressin secretion and thirst in health and disease. Clin Endocrinol 1988; 29: 549-76
32. Moses AM, Miller M. Osmotic threshold for vasopressin release as determined by hypertonic saline infusion and dehydration. Neuroendocrinology 1971; 7: 219-26
33. Thompson CJ, Selby P, Baylis PH. Reproducibility of osmotic and non-osmotic tests of vasopressin secretion in man. Am J Physiol 1991; 60: R533-9
34. Durr JA, Stamoutsos BA, Lindheimer MD. Osmoregulation during pregnancy in the rat. Evidence for resetting of the threshold for vasopressin secretion during gestation. J Clin Invest 1981; 68: 337-46
35. Davison JM, Gilmore EA, Durr J, et al. Altered threshold for vasopressin secretion and thirst in human pregnancy. Am J Physiol 1984; 246: F105-9
36. Spruce BA, Baylis PH, Burd J, Watson MJ. Variation in osmoregulation of arginine vasopressin during the human menstrual cycle. Clin Endocrinol 1985; 22: 37-42
37. Evbuomwan IO, Davison JM, Baylis PH, Murdoch A. Altered osmotic thresholds for arginine vasopressin secretion and thirst during superovulation and in the ovarian hyperstimulation syndrome (OHSS): relevance to the pathophysiology of OHSS. Fertil Steril 2001; 75: 933-41
38. Miller M. Fluid and electrolyte homeostasis in the elderly: physiological changes of ageing and clinical consequences. Baillieres Clin Endocrinol Metab 1997; 11: 367-87
39. Johnson AG, Crawford GA, Kelly D. Arginine vasopressin and osmolality in the elderly. J Am Geriatr Soc 1994; 42: 399-404
40. Helderman JH, Vestal RE, Rowe JW, et al. The response of arginine vasopressin to intravenous alcohol and hypertonic saline in man: the impact of ageing. J Gerontol 1978; 33: 39-47
41. Johnson JA, Zehr JE, Moore WW. Effects of separate and concurrent osmotic and volume stimuli on plasma ADH in sheep. Am J Physiol 1970; 218: 1273-80
42. Baylis PH. Posterior pituitary function in health and disease. Clin Endocrinol Metab 1983; 12: 747-70
43. Goetz KL, Zhu JL, Leadley RJ, et al. Hemodynamic and hormonal influences on the secretion of vasopressin. In: Jard S, Jamison R, eds. Vasopressin. Montrouge, France: John Libbey, 1991: 279-86
44. Dunn FL, Brennan TJ, Nelson AE, Robertson GL. The role of blood osmolality and volume in regulating vasopressin secretion in the rat. J Clin Invest 1973; 52: 3212-19
45. Goldsmith SR, Dodge D, Cowley AW. Nonosmotic influences on osmotic stimulation of vasopressin in humans. Am J Physiol 1987; 252: H85-8
46. Ukei M, Moran WH, Zimmerman B. The role of visceral afferent pathways on vasopressin secretion and urinary excretory patterns during surgical stress. Ann Surg 1968; 168: 16-28
47. Baylis PH, Robertson GL. Arginine vasopressin response to insulin-induced hypoglycemia in man. J Clin Endocrinol Metab 1981; 53: 935-40
48. Krigge U, Kjaer A, Kristofferson U, et al. Histamine and prostaglandin interaction in regulation of oxytocin and vasopressin secretion. J Neuroendocrinol 2003; 15: 940-5
49. McKinley MJ, Mathai M, McAllen RM, et al. Vasopressin secretion: osmotic and hormonal regulation by the lamina terminalis. J Neuroendocrinol 2004; 16: 340-7
50. Cunningham JT, Bruno SB, Grindstaff RR, et al. Cardiovascular regulation of supraoptic vasopressin neurons. Prog Brain Res 2002; 139: 257-73
51. Ishikawa S, Schrier RW. Pathophysiological roles of arginine vasopressin and aquaporin-2 in impaired water excretion. Clin Endocrinol 2003; 58: 1-17
52. Kombian SB, Hirasawa M, Mouginot D, et al. Modulation of synaptic transmission by oxytocin and vasopressin in the supraoptic nucleus. Prog Brain Res 2002; 139: 235-46
53. Ludwig M, Sabatier N, Dayanilhi G, et al. The active role of dendrites in the regulation of magnocellular neurosecretory cell behavior. Prog Brain Res 2002; 139: 247-56
54. Thrasher TN, Keil LC, Ramsay DJ. Lesions of the organum vasculosum of the lamina terminalis (OVLT) attenuate osmotically-induced drinking and vasopressin secretion in the dog. Endocrinology 1982; 110: 1837-9
55. Thompson CJ, Burd JM, Baylis PH. Acute suppression of plasma vasopressin and thirst after drinking in hypernatremic humans. Am J Physiol 1987; 252: R1138-42
56. Andersson B, Rundgroen M. Thirst and its disorders. Ann Rev Med 1982; 33: 231-9
57. Fitzsimons JT. The physiological basis of thirst. Kidney Int 1976; 10: 3-11
58. McKinley MJ, Denton DA, Park RG, Weisinger RS. Ablation of subfornical organ does not prevent angiotensin-induced water drinking in sheep. Am J Physiol 1986; 250: R1052-9
59. Thompson CJ, Bland J, Burd J, Baylis PH. The osmotic thresholds for thirst and vasopressin release are similar in healthy man. Clin Sci 1986; 71: 651-6
60. Thompson CJ. Polyuric states in man. In: Baylis PH, ed. Water and Salt Homeostasis in Health and Disease. London: Bailliere Tindall, 1989: 473-97
61. Robertson GL. Diabetes insipidus. Endocrinol Metab Clin North Am 1995; 24: 549-72
62. Baylis PH, Cheetham T. Diabetes insipidus. Arch Dis Child 1998; 79: 84-9
63. Ball SG, Baylis PH. The neurohypophysis. In: Wass JH, Shalet SM, eds. Oxford Textbook of Endocrinology and Diabetes. Oxford: Oxford Univesrity Press, 2002: 87-99
64. Maghnie M, Cosi G, Genovese R, et al. Central diabetes insipidus in children and young adults. N Engl J Med 2000; 343: 998-1007
65. Hollinshead WH. The interphase of diabetes insipidus. Proc Mayo Clin 1964; 39: 95-100
66. Baylis PH, Thompson CJ, Burd JM, et al. Recurrent pregnancy-induced polyuria and thirst due to hypothalamic diabetes insipidus: an investigation into possible mechanisms responsible for polyuria. Clin Endocrinol 1986; 24: 459-66
67. Barron WM, Cohen LH, Ulland LA, et al. Transient vasopressin-resistant diabetes insipidus of pregnancy. N Engl J Med 1984; 310: 442-4
68. Maghnie M, Altobelli M, Iorgin N-D, et al. Idiopathic central diabetes insipidus is associated with abnormal blood supply to the posterior pituitary gland caused by vascular impairment of the inferior hypophyseal artery system. J Clin Endocrinol Metab 2004; 89: 1891-6
69. Pivoello R, De Bellis A, Faggiano A, et al. Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical, immunological, and radiological features in a large cohort of patients with central diabetes insipidus of known and unknown etiology. J Clin Endocrinol Metab 2003; 88: 1629-36
70. Ito M, Jameson JL, Ito M. Molecular basis of autosomal dominant neurohypophyseal diabetes insipidus. Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum. J Clin Invest 1997; 99: 2897-905
71. Eubank S, Nguyen TL, Deeb R, et al. Effects of diabetes insipidus mutations on neurophysin folding and function. J Biol Chem 2001; 276: 29671-80
72. Davies J, Murphy D. Autophagy in hypothalamic neurones of rats expressing a familial neurohypophyseal diabetes insipidus transgene. J Neuroendocrinol 2002; 14: 629-37
73. Rittig S, Sigaard C, Ozata M, et al. Autosomal dominant neurohypophyseal diabetes insipidus due to substitution of histidine for tyrosine-2 in the vasopressin moiety of the hormone precursor. J Clin Endocrinol Metab 2002; 87: 3351-5
74. Christenson JH, Sigaard C, Corydon TJ, et al. Impaired trafficking of mutated AVP prohormone in cells expressing rare disease genes causing autosomal dominant familial neurohypophyseal diabetes insipidus. Clin Endocrinol 2004; 60: 125-36
75. Elias PCL, Ellias LLK, Torres N, et al. Progressive decline of vasopressin secretion in familial autosomal dominant neurohypophyseal diabetes insipidus presenting a novel mutation in the vasopressin-neurophysin II gene. Clin Endocrinol 2003; 59: 511-18.
76. Barrett TG, Bundey S. Wolfram (DIDMOAD) syndrome. J Med Genet 1997; 34: 838-41
77. Cryns K, Sivakumaran TA, Van den Ouweland JMW, et al. Mutational spectrum of the WFS1 gene in wolfram syndrome, non-syndromic hearing impairment, diabetes mellitus and psychiatric disease. Hum Mutat 2003; 22: 275-87
78. Domenecch E, Gomez-Zaera M, Nunes V. WFS1 mutations in Spanish patients with diabetes mellitus and deafness. Eur J Hum Genet 2002; 10: 421-6
79. Barbieris C, Mouillac B, Durroux T. Structural basis of vasopressin/oxytocin receptor function. J Endocrinol 1998; 156: 223-9
80. Mulders SM, Bichet DG, Rijss JP, et al. An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. J Clin Invest 1998; 102: 57-66
81. Asai T, Kuwahara M, Kurihara H, et al. Pathogenesis of nephrogenic diabetes insipidus by aquaporin-2 c-terminus mutations. Kidney Int 2003; 64: 2-10
82. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med 2000; 342: 1581-9
83. Rolls B. Thirst in human hypo- and hypernatremic states. In: Jard S, Jamison R, eds. Vasopressin. Montrouge, France: John Libbey, 1991: 549-56
84. Zerbe R, Stropes L, Robertson GL. Vasopressin function in the syndrome of inappropriate antidiuresis. Ann Rev Med 1980; 31: 315-27
85. Smith D, McKenna K, Moore K, et al. Baroregulation of vasopressin release in adipsic diabetes insipidus. J Clin Endocrinol Metab 2002; 87: 4564-8
86. Fried LF, Palevsky PM. Hyponatremia and hypernatremia. Med Clin North Am 1997; 81: 585-609
87. Robertson GL, Aycinena P, Zerbe RL. Neurogenic disorders of osmoregulation. Am J Med 1982; 72: 339-53
88. Nguyen BN, Yablon SA, Chen SY. Hypodipsic hypernatraemia and diabetes insipidus following anterior communicating artery aneurysm clipping: diagnostic and therapeutic challenges in the amnestic rehabilitation patient. Brain Inj 2001; 15: 975-980
89. McKenna K, Thompson C. Osmoregulation in clinical disorders of thirst and thirst appreciation. Clin Endocrinol 1998; 49: 139-152
90. Hammond DN, Moll GW, Robertson GL, Chelmicka-Schorr E. Hypodipsic hypernatremia with normal osmoregulation of vasopressin. N Engl J Med 1986; 315: 433-6
91. Ball SG, Barber T, Baylis PH. Tests of posterior pituitary function. J Endocrinol Invest 2003; 26(Suppl.): 15-24
92. Zerbe RL, Robertson GL. A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria. N Engl J Med 1981; 305: 1539-46
93. Robertson GL. Diagnosis of diabetes insipidus. In: Czernichow P, Robinson AG, eds. Diabetes Insipidus in Man: Frontiers of Hormone Research, vol. 13. Basel: S Karger, 1985: 176-89
94. Baylis PH, Robertson GL. Vasopressin response to hypertonic saline infusion to assess posterior pituitary function. J R Soc Med 1980; 73: 255-60
95. Diedrich S, Eckmanns T, Exner P, et al. Differential diagnosis of polyuric/polydipsic syndromes with the aid of urinary vasopressin measurement in adults. Clin Endocrinol 2001; 54: 665-71
96. Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 1967; 42: 790-806
97. Anderson RJ, Chung H-M, Kluge R, Schrier RW. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. Ann Intern Med 1985; 102: 164-8
98. Gross PA, Pehrisch H, Rascher W, et al. Pathogenesis of clinical hyponatremia: observations of vasopressin and fluid intake in 100 hyponatremic medical patients. Eur J Clin Invest 1987; 17: 123-9
99. Ishikawa S-E, Saito T, Fugagawa A, et al. Close association of urinary excretion of aquaporin-2 with appropriate and inappropriate arginine vasopressin dependent antidiuresis in hyponatraemia in elderly subjects. J Clin Endocrinol Metab 2001; 86: 1665-71
100. Saito T, Higashiyama M, Nakamura T, et al. Urinary excretion of the aquaporin-2 water channel exaggerated in pathological states of impaired water excretion. Clin Endocrinol 2001; 55: 217-21
101. Pedersen RS, Bentzen H, Bech JN, et al. Effect of water deprivation and hypertonic saline infusion on urinary AQP2 excretion in healthy humans. Am J Physiol (Renal Physiol) 2001; 280: F860-7
102. Ball SG, Vaidja B, Baylis PH. Hypothalamic adipsic syndrome: diagnosis and management. Clin Endocrinol 1997; 47: 405-9